Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer

Journal article

Peer reviewed

Ronald D Alvarez, Ursula A Matulonis, Thomas J Herzog, Robert L Coleman, Bradley J Monk and Maurie Markman

Gynecologic oncology, Vol.141(3), pp.405-409

06/01/2016

PMID: 27049967

Abstract

Drug Resistance, Neoplasm

Female

Humans

Neoplasm Recurrence, Local - diagnosis

Neoplasm Recurrence, Local - drug therapy

Organoplatinum Compounds - pharmacology

Ovarian Neoplasms - diagnosis

Ovarian Neoplasms - drug therapy

Practice Guidelines as Topic

1 Record Views

Title: Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer
Creators: Ronald D Alvarez - University of Alabama at Birmingham
Ursula A Matulonis - Dana-Farber Cancer Institute
Thomas J Herzog - University of Cincinnati
Robert L Coleman - The University of Texas MD Anderson Cancer Center
Bradley J Monk - University of Arizona
Maurie Markman - Cancer Treatment Centers of America
Publication Details: Gynecologic oncology, Vol.141(3), pp.405-409
Identifiers: 991005968889302656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article